# China NMPA Inspection - Henan Shengwang Pharmaceutical Co., Ltd. - December 05, 2017

Source: https://www.globalkeysolutions.net/records/china_inspection/henan-shengwang-pharmaceutical-co-ltd/227b8567-bfa5-4f93-bc02-8bb6f70abf02/
Source feed: China

> China NMPA unannounced inspection for Henan Shengwang Pharmaceutical Co., Ltd. published December 05, 2017. An unannounced inspection by the NMPA of Henan Shengwang Pharmaceutical Co., Ltd., located at No. 666, Longxiang Middle Road, Nanyang City, was conduc

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Forwarding the notification from the Henan Provincial Food and Drug Administration regarding the surprise inspection of Henan Shengwang Pharmaceutical Co., Ltd.
- Company Name: Henan Shengwang Pharmaceutical Co., Ltd.
- Publication Date: 2017-12-05
- Product Type: Cosmetics
- Summary: An unannounced inspection by the NMPA of Henan Shengwang Pharmaceutical Co., Ltd., located at No. 666, Longxiang Middle Road, Nanyang City, was conducted from November 3rd to November 5th, 2017. The inspection identified numerous critical deficiencies in the company's operations and quality management systems, indicating a significant departure from regulatory requirements for cosmetic manufacturing.

Key violations included organizational discrepancies, such as an inaccurate organizational chart, undefined job responsibilities, and a quality manager lacking the necessary qualifications. The company failed to maintain essential documentation, including production and inspection records for sampled products, retention samples, and critical quality management systems like product release and traceability. Expired raw materials, notably the pharmaceutical ingredient furacilin, were found, alongside an unapproved "wound disinfection spray" being trial-produced on cosmetic lines, posing serious cross-contamination risks. Facility hygiene was also severely lacking, with personal belongings in production areas, unsanitary floor drains, and inadequate changing room and laundry facilities. Warehouse management was substandard, featuring expired, unlabeled, and improperly stored raw materials, and poorly organized finished products without proper pest control.

Under the NMPA regulatory framework, Henan Shengwang Pharmaceutical Co., Ltd. was mandated to rectify all identified issues promptly and recall affected products. The case has been escalated to the Nanyang Municipal Bureau for further investigation and legal action.

Company: https://www.globalkeysolutions.net/companies/henan-shengwang-pharmaceutical-co-ltd/40a20d4f-4122-4610-bbef-9d5b2a46786d/